Is the Ramsay Health Care Limited (ASX:RHC) share price in the buy zone?

Although the Ramsay Health Care Limited (ASX: RHC) share price finished the day slightly higher on Thursday, at one stage the private hospital operator’s shares tumbled to a multi-year low of $53.01.

At that point Ramsay Health Care’s shares were down a remarkable 30% since peaking at $76.18 in August of last year.

Is Ramsay Health Care cheap enough to buy now?

While Ramsay Health Care’s shares are becoming a lot more attractive now after this sizeable decline, I wouldn’t be a buyer just yet.

After all, as I mentioned at the start of the week, Goldman Sachs initiated coverage on the private hospital operator with a sell rating and $49.00 price target. Which could mean it still has further to fall.

This bearish call was made on the belief that Ramsay Health Care’s shares are overvalued and that it faces challenging industry dynamics from rising healthcare costs and the decline in private health insurance (PHI) participation.

So although its shares hit a multi-year low today, they would have to fall a lot further before I would be willing to invest.

What is a good buy price?

I would be interested in picking up shares in Ramsay Health Care if they fell to $45.00 or below. At this level I think they provide a decent risk/reward, especially for a long-term investment.

Based on Goldman’s forecast for earnings per share of $2.86 in FY 2019, Ramsay Health Care’s shares would be trading on a forward price to earnings ratio of just under 16x if they came down to the $45.00 mark. I think this earnings multiple is more befitting for its current growth profile.

But until that happens, I plan to stay away from the company’s shares and focus on other healthcare options such as CSL Limited (ASX: CSL) and Cochlear Limited (ASX: COH).

Alternatively, this ASX small cap healthcare share is up 285% with no sign of stopping...

One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...

To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!